19.4 Neurodegenerative Diseases and Cognition

Neurodegenerative diseases like Alzheimer's, Parkinson's, and Huntington's wreak havoc on our brains, causing memory loss, cognitive decline, and motor issues. These conditions stem from protein misfolding, oxidative stress, and neuronal death, progressively damaging key brain regions.

Diagnosing these diseases involves clinical assessments, brain scans, and biomarker tests. Treatment options include medications to manage symptoms, cognitive therapies, and lifestyle changes. Emerging approaches like immunotherapies and gene therapies offer hope for slowing or halting disease progression in the future.

Neurodegenerative Diseases and Their Impact on Cognition

Changes in neurodegenerative diseases

Top images from around the web for Changes in neurodegenerative diseases

• 

  2.4 Chronic Neurodegenerative Diseases – Neuroscience: Canadian 2nd Edition View original

  Is this image relevant?

• 

  Frontiers | Systems Biology Approaches to Understand the Host–Microbiome Interactions in ... View original

  Is this image relevant?

• 

  Neuroradiology and Its Role in Neurodegenerative Diseases View original

  Is this image relevant?

• 

  2.4 Chronic Neurodegenerative Diseases – Neuroscience: Canadian 2nd Edition View original

  Is this image relevant?

• 

  Frontiers | Systems Biology Approaches to Understand the Host–Microbiome Interactions in ... View original

  Is this image relevant?

1 of 3

Top images from around the web for Changes in neurodegenerative diseases

• 

  2.4 Chronic Neurodegenerative Diseases – Neuroscience: Canadian 2nd Edition View original

  Is this image relevant?

• 

  Frontiers | Systems Biology Approaches to Understand the Host–Microbiome Interactions in ... View original

  Is this image relevant?

• 

  Neuroradiology and Its Role in Neurodegenerative Diseases View original

  Is this image relevant?

• 

  2.4 Chronic Neurodegenerative Diseases – Neuroscience: Canadian 2nd Edition View original

  Is this image relevant?

• 

  Frontiers | Systems Biology Approaches to Understand the Host–Microbiome Interactions in ... View original

  Is this image relevant?

1 of 3

• Alzheimer's disease
  • Memory loss impairs short-term recall and formation of new memories
  • Problem-solving and planning skills deteriorate affecting daily functioning
  • Language skills decline leading to word-finding difficulties and reduced comprehension
  • Disorientation causes confusion about time, date, and location
  • Mood and personality shifts result in increased irritability or withdrawal
  • Everyday tasks become challenging due to cognitive decline (preparing meals, managing finances)
• Parkinson's disease
  • Cognitive slowing (bradyphrenia) leads to delayed information processing and responses
  • Executive function deficits impair organization, planning, and multitasking abilities
  • Visuospatial impairments affect depth perception and navigation (difficulty judging distances)
  • Attention problems result in difficulty focusing and increased distractibility
  • Depression and anxiety frequently co-occur affecting overall quality of life
  • Impulse control disorders may develop (compulsive gambling, shopping, or hypersexuality)
• Huntington's disease
  • Impaired executive functions affect decision-making and problem-solving abilities
  • Attention and concentration deficits lead to difficulty staying focused on tasks
  • Memory problems impact both short-term and long-term recall
  • Emotional disturbances manifest as irritability, depression, and mood swings
  • Impulsivity and disinhibition result in socially inappropriate behaviors
  • Motor symptoms (chorea) cause involuntary, jerky movements affecting coordination

Neuropathology of disease progression

• General mechanisms
  • Protein misfolding and aggregation form toxic clumps disrupting cellular function
  • Oxidative stress damages cellular components through free radical accumulation
  • Mitochondrial dysfunction impairs energy production in neurons
  • Neuroinflammation triggers immune responses potentially damaging healthy tissue
  • Synaptic dysfunction leads to impaired communication between neurons
• Alzheimer's disease pathology
  • Amyloid-beta plaques accumulate in extracellular spaces disrupting neural networks
  • Neurofibrillary tangles (tau protein) form inside neurons impairing cellular transport
  • Neuronal loss in hippocampus and cortex results in severe memory and cognitive deficits
• Parkinson's disease pathology
  • Loss of dopaminergic neurons in substantia nigra leads to motor and cognitive symptoms
  • Alpha-synuclein aggregates (Lewy bodies) form within neurons disrupting cellular function
  • Disruption of basal ganglia circuits affects movement control and cognitive processes
• Huntington's disease pathology
  • CAG repeat expansion in huntingtin gene causes production of mutant protein
  • Mutant huntingtin protein aggregates form toxic clumps within neurons
  • Striatal and cortical atrophy results in progressive motor and cognitive decline

Diagnosis and Treatment of Neurodegenerative Diseases

Assessment of neurodegenerative disorders

• Clinical assessment
  • Medical history gathers information on symptoms, progression, and risk factors
  • Physical and neurological examination evaluates motor function, reflexes, and sensory responses
  • Cognitive testing (Mini-Mental State Examination, Montreal Cognitive Assessment) assesses various cognitive domains
  • Behavioral and psychiatric evaluation identifies mood disorders and personality changes
• Neuroimaging techniques
  • Magnetic Resonance Imaging (MRI) visualizes brain structure and detects atrophy patterns
  • Positron Emission Tomography (PET) measures metabolic activity and protein aggregates (amyloid, tau)
  • Single-Photon Emission Computed Tomography (SPECT) assesses blood flow and dopamine transporter levels
• Biomarkers
  • Cerebrospinal fluid (CSF) analysis measures levels of disease-specific proteins (amyloid-beta, tau)
  • Blood-based biomarkers detect circulating markers of neurodegeneration (neurofilament light chain)
  • Genetic testing identifies disease-causing mutations or risk factors (APOE genotype for Alzheimer's)
• Diagnostic criteria
  • DSM-5 criteria for neurocognitive disorders provide standardized diagnostic guidelines
  • Specific criteria for each disease (National Institute on Aging-Alzheimer's Association criteria for Alzheimer's) ensure accurate diagnosis

Treatment options for cognitive functioning

• Current pharmacological treatments
  • Cholinesterase inhibitors for Alzheimer's disease improve cognitive symptoms by increasing acetylcholine levels
  • Levodopa and dopamine agonists for Parkinson's disease alleviate motor symptoms and some cognitive deficits
  • Tetrabenazine for Huntington's disease chorea reduces involuntary movements
• Non-pharmacological interventions
  • Cognitive stimulation therapy engages patients in mentally stimulating activities to maintain cognitive function
  • Physical exercise improves cardiovascular health and potentially slows cognitive decline
  • Occupational therapy helps patients adapt to cognitive changes and maintain independence
  • Speech and language therapy addresses communication difficulties and swallowing problems
• Emerging therapies
  • Immunotherapies targeting protein aggregates aim to clear toxic proteins from the brain
  • Gene therapies attempt to correct or compensate for disease-causing genetic mutations
  • Stem cell treatments explore the potential for neural regeneration and repair
  • Neuroprotective agents seek to slow or halt the progression of neurodegeneration
• Potential future approaches
  • Personalized medicine based on genetic profiles tailors treatments to individual patients
  • Combination therapies targeting multiple pathways address the complex nature of neurodegenerative diseases
  • Brain-computer interfaces for cognitive enhancement may compensate for lost functions
  • Nanotechnology-based drug delivery systems improve targeted treatment delivery to the brain